Overview
Gaucher’s disease is a rare inherited metabolic disorder where the body lacks enough of an enzyme called glucocerebrosidase, which breaks down a fatty substance called glucocerebroside. Without this enzyme, the fatty substance builds up in organs like the liver, spleen, and bone marrow, leading to enlargement and dysfunction. It is a genetic condition, meaning a person must inherit two faulty copies of the gene (one from each parent) to have the disease.

Why It’s Important
Although rare, Gaucher’s disease can cause severe organ damage, bone complications, and blood problems if left undiagnosed or untreated. Some forms are mild and manageable, while others can lead to life-threatening neurological decline. Early diagnosis and treatment, especially with modern therapies, can prevent long-term complications and improve quality of life significantly.

Quick Facts

• Affects both children and adults; some forms appear in infancy

• Most common among people of Ashkenazi Jewish descent

• Estimated to affect about 1 in 40,000 to 60,000 people

• Chronic genetic condition; not contagious

• Three main types:

  • Type 1: non-neuropathic (most common and treatable)

  • Type 2: acute neuropathic (severe, appears in infancy)

  • Type 3: chronic neuropathic (moderate, slow-progressing)

What Happens in the Body
In healthy individuals, glucocerebrosidase breaks down fatty waste in cells. In Gaucher’s disease, the enzyme doesn’t work properly, causing fat-laden cells (Gaucher cells) to accumulate in organs. This disrupts normal function, leading to organ enlargement, bone marrow suppression, and skeletal damage. The severity and organs affected depend on the type.

Common Signs and Symptoms

• Enlarged liver and spleen (abdominal swelling)

• Fatigue and weakness

• Easy bruising and frequent nosebleeds

• Low platelet count (thrombocytopenia)

• Bone pain, fractures, or bone thinning (osteopenia)

• In types 2 and 3: neurological issues like seizures, eye movement problems, or developmental delay

Diagnosis

• Blood enzyme test (to measure glucocerebrosidase activity)

• Genetic testing to confirm mutations in the GBA gene

• Bone scans to assess skeletal damage

• MRI or ultrasound to evaluate organ size
  See a doctor if:

• There’s unexplained organ swelling, chronic fatigue, or a family history of Gaucher’s

• Symptoms appear in childhood or worsen progressively

• You are of Ashkenazi Jewish descent and plan to have children (genetic carrier screening available)

Treatment and Management

• Enzyme Replacement Therapy (ERT) (mainstay for Type 1 and some Type 3)

  • Delivered through IV infusions every 2 weeks

• Substrate Reduction Therapy (SRT)

  • Oral medications that reduce the buildup of glucocerebroside

• Bone health management: vitamin D, calcium, physical therapy

• Surgery (in rare cases) to remove spleen

• Neurological symptoms (in Type 2 and 3) have limited treatment options

• Lifelong management is typically needed; no cure, but treatable

Risks and Complications

• Fractures and joint collapse

• Severe anemia and bleeding issues

• Growth delays in children

• Parkinson’s disease risk is higher in carriers and patients

• In Type 2: neurological deterioration and shortened lifespan

Who Is at Risk

• People of Ashkenazi Jewish heritage (higher carrier rate)

• Children of two carrier parents (25% chance of disease)

• Siblings of affected individuals

• Carriers may not show symptoms but can pass on the gene

Related Conditions

• Other lysosomal storage disorders (e.g., Tay-Sachs, Niemann-Pick)

• Parkinson’s disease (related via GBA gene mutations)

• Osteopenia or osteoporosis

• Anemia and thrombocytopenia

When to See a Doctor

• If you or your child have unexplained organ swelling, bone pain, or unusual bleeding

• If you have a family history or are part of a high-risk group and plan to conceive

• If a sibling or relative is diagnosed with Gaucher’s disease

Last Updated: June 28, 2025